GlassScriptPhysician profile
Tae Y Yang
NPI 1821262072
$13,852.37
in general payments reported to CMS, 2019-2025
47 companies · $1,779 in 2025
The $1,779 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,399 · 2020: $735 · 2021: $1,570 · 2022: $3,340 · 2023: $2,591 · 2024: $2,440 · 2025: $1,779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,809.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,437.60 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $1,263.44 | 2019-2025 | |
| Medtronic, INC. | $1,186.90 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Symplicity G3 |
| Abbott Laboratories | $1,079.78 | 2019-2025 | Cardiomems, Xience Sierra, Jot Dx |
| Pfizer INC. | $1,013.16 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $758.63 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $624.08 | 2019-2024 | Xarelto |
| Shockwave Medical, INC | $560.73 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Sanofi-Aventis U.S. LLC | $513.85 | 2019-2024 | |
| Inari Medical, INC. | $500.53 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biotronik INC. | $490.58 | 2021-2024 | Biomonitor, Amvia Edge, Acticor 7 Vr-T Dx |
| Abiomed | $471.58 | 2019-2024 | Impella |
| E.R. Squibb & Sons, L.L.C. | $405.88 | 2019-2025 | Camzyos, Eliquis |
| Atricure, INC. | $405.29 | 2022-2025 | Atriclip Laa Exclusion System |
| Boston Scientific Corporation | $317.02 | 2019-2024 | Sentinel, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $300.88 | 2021-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $257.13 | 2019-2024 | Farxiga, Wainua |
| Alnylam Pharmaceuticals INC. | $245.47 | 2022-2025 | Amvuttra, Onpattro |
| Merck Sharp & Dohme LLC | $241.53 | 2022-2025 | Verquvo |
| Astellas Pharma US INC | $179.43 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $132.70 | 2021-2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $131.70 | 2022-2025 | Assure Wcd |
| Novo Nordisk INC | $125.93 | 2024-2025 | Ozempic, Wegovy |
| Regeneron Healthcare Solutions, INC. | $119.23 | 2019-2022 | |
| Scpharmaceuticals INC. | $114.95 | 2024-2025 | |
| Cardiovascular Systems INC. | $107.00 | 2019-2022 | |
| Amarin Pharma, INC. | $105.17 | 2019-2022 | |
| Cardiva Medical, INC. | $73.17 | 2022-2024 | Savvywire, Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Bayer Healthcare Pharmaceuticals INC. | $70.99 | 2021-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $62.66 | 2024 | Arcalyst |
| Terumo Medical Corporation | $62.26 | 2019-2022 | |
| Bridgebio Pharma, INC. | $58.21 | 2025 | Attruby |
| Edwards Lifesciences Corporation | $56.68 | 2019-2023 | Sapien 3 Ultra Resilia |
| Actelion Pharmaceuticals US, INC. | $54.62 | 2023-2025 | Uptravi, Opsumit |
| W. L. Gore & Associates, INC. | $52.77 | 2022 | |
| Cathworks, INC. | $39.40 | 2021-2022 | |
| Heartflow, INC. | $39.05 | 2025 | |
| Amryt Pharma Holdings LTD | $28.06 | 2021-2023 | Juxtapid |
| Otsuka America Pharmaceutical, INC. | $23.64 | 2019 | |
| Convatec INC. | $21.75 | 2025 | |
| Philips North America LLC | $21.12 | 2024 | (Ck7) Extended Holter |
| Lilly USA, LLC | $19.39 | 2024 | Jardiance, Zepbound |
| Irhythm Technologies, INC. | $18.04 | 2024 | Zio Xt Patch, Zio Monitor |
| Teleflex LLC | $16.58 | 2019 | |
| Medtronic Vascular, INC. | $15.26 | 2020 | |
| Portola Pharmaceuticals, LLC | $14.35 | 2019 | |
| Zoll Respicardia, INC. | $14.20 | 2025 | Remede System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tae Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.